CD34+CD38– is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells

BACKGROUND : Ex vivo expansion of HPCs is an attractive approach to overcoming the current limitations of human cord blood transplantation. It is important not only to define the optimal culture conditions but also to know the number of progenitor cells that can be obtained. CD34+ cells have a great variability in their cloning capacity and in their ability to expand HPCs. This study was carried out to assess whether this variability could be due to intrinsic or extrinsic factors.

[1]  G. Sanz.  Unrelated donor umbilical cord blood transplantation in adults with hematologic malignancies. , 2005, Pathologie-biologie.

[2]  P. Bolufer,et al.  Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. , 2001, Blood.

[3]  Mang Xiao,et al.  Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level. , 2001, Experimental hematology.

[4]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[5]  C. Eaves,et al.  During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts. , 2000, Blood.

[6]  J. Adamson,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS , 2022 .

[7]  N. Fortunel,et al.  Release from Quiescence of Primitive Human Hematopoietic Stem/Progenitor Cells by Blocking Their Cell‐Surface TGF‐β Type II Receptor in a Short‐Term In Vitro Assay , 2000, Stem cells.

[8]  B. Verhasselt,et al.  Thymic repopulation by CD34(+) human cord blood cells after expansion in stroma-free culture. , 1999, Blood.

[9]  C. Eaves,et al.  Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. , 1999, Blood.

[10]  A. Ho,et al.  Correlation Between IL‐3 Receptor Expression and Growth Potential of Human CD34+ Hematopoietic Cells from Different Tissues , 1999, Stem cells.

[11]  A. Nagler,et al.  The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice. , 1999, Blood.

[12]  M. Goldaniga,et al.  ADULT REFRACTORY CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA: CAN DAPSONE BE PROPOSED AS SECOND‐LINE THERAPY? , 1999, British journal of haematology.

[13]  Z. Desai,et al.  CD34+CD38−HLA‐DR− CORRELATE MORE CLOSELY THAN CD34+CD38− WITH ENGRAFTMENT POST‐PBSC TRANSPLANTATION , 1999, British journal of haematology.

[14]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[15]  Ph,et al.  Primordial role of CD34+38− cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation , 1998, British journal of haematology.

[16]  B. Lord,et al.  CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors , 1998, Stem cells.

[17]  Y. Sonoda,et al.  Human cord blood-derived primitive progenitors are enriched in CD34+c-kit− cells: correlation between long-term culture-initiating cells and telomerase expression , 1998, Leukemia.

[18]  Lesley J. Murray,et al.  Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. , 1998, Blood.

[19]  C. Eaves,et al.  High‐resolution cell division tracking demonstrates the Flt3‐ligand‐dependence of human marrow CD34+CD38− cell production in vitro , 1997, British journal of haematology.

[20]  J. Dick,et al.  Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture , 1997, The Journal of experimental medicine.

[21]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[23]  G. Crooks,et al.  Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. , 1996, Blood.

[24]  G. Crooks,et al.  A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. , 1995, Blood.

[25]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Dick,et al.  Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. , 2000, Blood.

[27]  J. García,et al.  Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). , 1997 .